MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Alexandria Forbes Sells 35,839 Shares

MeiraGTx Holdings plc (NASDAQ:MGTX) CEO Alexandria Forbes sold 35,839 shares of the stock in a transaction that occurred on Tuesday, January 7th. The shares were sold at an average price of $6.47, for a total transaction of $231,878.33. Following the completion of the transaction, the chief executive officer now owns 1,395,102 shares in the company, valued at $9,026,309.94. This represents a 2.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

MeiraGTx Stock Performance

Shares of MGTX stock traded down $0.15 during trading hours on Friday, hitting $6.20. The stock had a trading volume of 463,403 shares, compared to its average volume of 307,667. The firm has a market capitalization of $484.55 million, a PE ratio of -5.12 and a beta of 1.26. MeiraGTx Holdings plc has a twelve month low of $3.85 and a twelve month high of $7.37. The stock’s 50 day moving average is $6.28 and its 200 day moving average is $5.12. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34.

Institutional Investors Weigh In On MeiraGTx

Hedge funds have recently modified their holdings of the stock. BNP Paribas Financial Markets lifted its holdings in shares of MeiraGTx by 142.5% during the third quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock worth $39,000 after purchasing an additional 5,476 shares during the period. China Universal Asset Management Co. Ltd. lifted its holdings in MeiraGTx by 97.0% in the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock valued at $62,000 after acquiring an additional 7,330 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in MeiraGTx by 19.0% in the second quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after acquiring an additional 2,839 shares during the period. SG Americas Securities LLC acquired a new stake in MeiraGTx in the third quarter valued at $82,000. Finally, Hsbc Holdings PLC lifted its holdings in MeiraGTx by 100.9% in the second quarter. Hsbc Holdings PLC now owns 23,954 shares of the company’s stock valued at $102,000 after acquiring an additional 12,029 shares during the period. 67.48% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Royal Bank of Canada increased their price target on shares of MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. Chardan Capital reissued a “buy” rating and issued a $36.00 price objective on shares of MeiraGTx in a report on Monday, November 18th.

About MeiraGTx

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.